When appetite drops, the log's job changes from catching excess to catching gaps#
If a GLP-1 medication such as semaglutide or tirzepatide has cut your appetite, the most useful things to track are no longer the extra calories you might overeat. They are the things that can quietly go missing: protein, fluids, the variety of foods that supply vitamins and minerals, and the side effects that shape what you can eat on a given day. Rough calories still matter, but mainly as a check that intake has not fallen too far, not as a ceiling to stay under.
This is general information, not medical advice. The prescribing clinician and, ideally, a registered dietitian set your targets and adjust the plan. A food log is most valuable here as a record you can bring to those appointments.
Intake can fall by a sixth to more than a third, and nutrients fall with it#
A 2025 clinical advisory issued jointly by the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society summarizes the evidence this way: people using GLP-1s for obesity "experience significant reductions in appetite and energy intake, with observed caloric reductions of 16%–39%." It warns that this "large, rapid reduction can lead to insufficient intakes of essential vitamins and minerals, especially at energy intakes <1200 kcal/d for females and <1800 kcal/d for males"1.
The nutrients it names as examples of concern are iron, calcium, magnesium, zinc, and vitamins A, D, E, K, B1, B12 and C. That list is the practical reason a calorie total alone is the wrong summary for someone eating much less: you can hit a sensible calorie number on a narrow set of foods and still fall short on several vitamins and minerals.
On these medications, the risk a food log catches is usually what is missing, not what is extra.
For scale, the medications themselves are powerful. In the STEP 1 trial, 1,961 adults without diabetes took once-weekly semaglutide 2.4 mg or placebo plus lifestyle intervention for 68 weeks; mean weight change was −14.9% versus −2.4%2. In SURMOUNT-1, 2,539 adults took tirzepatide or placebo for 72 weeks; mean change was −15.0% at 5 mg, −19.5% at 10 mg and −20.9% at 15 mg, versus −3.1% on placebo3. Both trials were funded by the manufacturers of the drugs they tested. Both enrolled adults without diabetes who had obesity, or overweight plus a weight-related condition. Neither tested food-logging strategies, so they show average weight changes in the populations studied, not how to track. That is why the rest of this article leans on the advisory's clinical guidance rather than on trial outcomes.
What to include in your log#
The table below lists practical suggestions for what to record and why, drawing on the advisory's priorities; it is not a ranking the studies tested.
| What to log | How precisely | Why it matters on a GLP-1 |
|---|---|---|
| Protein at each meal | Reasonably, by portion | Lean mass loss is a documented concern; target set with your clinician |
| Food groups and variety | Roughly: did you eat fruit, vegetables, dairy or alternatives, whole grains, legumes today? | Micronutrient gaps follow a narrow diet at low intake |
| Fluids | Roughly, by glasses or bottles | Nausea, vomiting or diarrhea can cause dehydration |
| Symptoms and dose changes | A few words per day | Side effects cluster around starting and increasing doses |
| Rough calories | A daily range | Helps your care team spot persistently low intake |
| Weight | Weekly trend | Tells your clinician how fast weight is changing |
Protein first. The protein target itself, and the evidence behind it, is covered in protein intake on GLP-1 medications. For logging purposes, the useful habit is noting protein at each eating occasion rather than only as a daily total, because small meals make it easy to reach evening well short.
Calories as a range, not a target. Start with rough portions and calorie estimates; your care team can advise whether more detail is needed, and how precise calorie tracking needs to be covers the general trade-off. The 1,200/1,800 figures are risk markers, not personal calorie targets; if your intake regularly sits near or below them, that is something to raise, not to celebrate. The broader question of very low intakes is in is 1,200 calories too low.
Variety, not a nutrient spreadsheet. Tracking a dozen micronutrients by hand is not realistic. A simple daily tick of food groups is a workable stand-in, and the advisory notes that clinicians may proactively consider supplements such as vitamin D, calcium, B12 or a multivitamin for at-risk nutrients. That decision belongs to them, with your log as input.
Symptoms and fluids belong in the same log as food#
Gastrointestinal side effects are common, especially in the first weeks and after each dose increase, and they tend to ease on a stable dose1. The rates are summarized in the protein article linked above; what matters for tracking is how symptoms and eating interact.
The advisory describes a specific trap: "Some individuals get caught in a cycle of not eating due to nausea, which worsens the symptoms, which then further reduces the likelihood of eating." It notes nausea often appears in the morning or after long periods without food, and suggests a small breakfast followed by small meals every three to four hours while drinking adequate fluids. It also notes that large and high-fat meals can worsen symptoms such as diarrhea, and that alcohol can worsen nausea and reflux.
Recording symptoms alongside meals can make that pattern easier to spot. A short note ("nausea until noon, skipped breakfast, 2 glasses water") next to the day's food is more useful to a clinician than a precise calorie count.
Fluids deserve their own line. The advisory reports that post-marketing reports have linked kidney problems at the start of treatment and during dose escalation to "volume depletion resulting from dehydration caused by nausea and vomiting," and says people with or at risk of kidney problems should be counseled on preventing dehydration. If you are eating much less, you are also getting less of the water that normally comes with food, so a rough count of drinks is worth keeping, especially on days with vomiting or diarrhea. Constipation is also common, and the advisory encourages adequate fluids and fiber from foods.
Make the log something your care team can read#
The advisory explicitly recommends that follow-up include "regular re-assessment of dietary intake and hydration, for example, using food logs and/or food photos," alongside checks of nutrient levels. That gives a food log a clear audience and a clear shape.
What tends to help at an appointment:
- A typical week, not a perfect one. Several ordinary days show real patterns; one carefully logged day does not.
- Dose dates marked. Noting when the dose changed makes it easy to see whether symptoms or intake shifted after it.
- Photos when words are hard. On low-appetite days, a quick photo of a half-finished plate records more than an estimate you do not feel like making. Photo food journaling covers how to make photos useful later.
- Eating changes, in plain words. The advisory notes many people report reduced interest in food and fewer cravings, while some develop aversions, and nausea can push people toward refined starches. A line like "can only face toast and crackers this week" tells a dietitian more than a number.
On whether structured nutrition support adds to the drug: the advisory reports that in STEP 3, semaglutide combined with intensive lifestyle intervention (30 counseling visits and eight initial weeks of meal replacements) produced a 16% reduction in body weight, compared with 14.9% in STEP 1 with general advice, while describing the overall findings on added lifestyle support as mixed. Those are different trials, so the comparison is suggestive, not a controlled test.
FAQ#
Should I still count calories on Ozempic or Mounjaro?#
Counting calories loosely can help, but mainly to spot intake falling too low rather than to cap it. Protein, fluids, food variety and side effects usually deserve more attention than an exact calorie total. Your prescriber sets the actual targets.
How little is too little to eat on a GLP-1 medication?#
There is no universal number, and your clinician should decide. The 2025 joint advisory flags a higher risk of vitamin and mineral shortfalls at intakes below about 1,200 kcal a day for women and 1,800 for men, which is a reason to raise a consistently low log with your care team.
What should I write in a food diary for my GLP-1 appointments?#
A few ordinary days of meals with rough portions and protein sources, fluids, symptoms such as nausea or constipation, the dates your dose changed, and any foods you can no longer tolerate. Photos are fine when writing feels like too much.
Why do I feel sick when I skip meals on semaglutide?#
Clinical guidance notes that nausea often appears in the morning or after long gaps without food, and that not eating can worsen it. Small, regular meals with enough fluid are the usual advice; persistent symptoms should go to your prescriber.
Sources#
- Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr. 2025;122(1):344–367.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216.
Source: BurnWeek — "What to track when a GLP-1 medication cuts your appetite", https://burnweek.fit/blog/tracking-calories-on-glp1-medications/. Licensed CC BY 4.0: free to quote or reuse with a link to this page.
